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NLRP3 axis do not prevent cardiac dysfunction in CASP  
  




Hemodynamic collapse and myocardial dysfunction are among the major causes of 
death in severe sepsis. The purpose of this study was to assess the role played by TLR4 
and by the NLRP3 inflammasome in the cardiac dysfunction that occurs after high-
grade polymicrobial sepsis. We performed the colon ascendens stent peritonitis (CASP) 
surgery in Tlr4-/-, Nlrp3-/- and caspase-1-/- mice. We also assessed for the first time the 
electrical heart function in the CASP model. The QJ interval was increased in wild-type 
C57BL/6J mice after CASP when compared to sham controls, a result paralleled by an 
increase in the cardiac action potential duration (APD). The decreases in ejection 
fraction (EF), left-ventricle end diastolic volume (LVEDV), stroke volume, and cardiac 
output found after CASP were similar among all groups of mice. Similar heart response 
was found when Nlrp3-/- mice were submitted to high-grade CLP. Despite developing 
cardiac dysfunction similar to wild-types after CASP, Nlrp3-/- mice had reduced 
circulating levels of IL-1β, IL-6 and TNF-α. Our results demonstrate that the genetic 
ablation of Tlr4, Nlrp3, and caspase-1 does not prevent the cardiac dysfunction, despite 
preventing the increase in pro-inflammatory cytokines, indicating that these are not 
feasible targets to therapy in high-grade sepsis. 
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Sepsis is life-threatening organ dysfunction caused by a dysregulated host 
response to infection [1]. The severe tissue damage caused by sepsis can result from an 
initial infection that cannot be contained by the host and spreads to assume systemic 
proportions, but also from an exacerbated pro-inflammatory response that causes more 
tissue damage than the initial infective insult. Lungs, liver, kidney, and heart are deeply 
affected and contribute to a general imbalance that may result in death [1]. 
Hemodynamic collapse and myocardial dysfunction with impaired contractility and 
diastolic function are among the major causes of death in severe sepsis. A role in 
cardiac dysfunction has been assigned to the exaggerated pro-inflammatory cytokine 
production found in sepsis [2].  
The peritonitis caused by cecal ligation and puncture (CLP) is the most widely used 
model of low-grade polymicrobial sepsis. Pro-inflammatory cytokine production, such 
as TNF-α [3] and IL-6 [4], plays a pivotal role in the pathophysiology of CLP and is 
mainly related to the activation of different sensors of the innate immune system. 
Despite the role of toll like receptor 4 (TLR4) in mediating acute myocardial 
dysfunction in endotoxemia and E. coli injection [5], previous works showed that the 
genetic ablation of TLR4 decreases survival and worsens cardiac function in CLP [6], 
an effect associated with the role of TLR4 in bacterial clearance and the compensatory 
increase in tissue-damage mediator IL-6. On the other hand, the genetic ablation of toll 
like receptor 2 (TLR2) [7] and also of MyD88 and TRIF [8]improves cardiac function 
in CLP, with a correspondent reduction in the amounts of systemic and cardiac 




inflammatory cytokines. Still, in low/medium-grade polymicrobial sepsis the genetic 
ablation of NLRP3 or IL-1β improves survival and increases bacterial clearance 
[9]while preserving cardiac function [10] and reducing the production of TNF-α and IL-
6 by cardiomyocytes [11]. 
The need for a high-model of polymicrobial sepsis emerged from the disparities 
between certain clinical conditions found in human sepsis and experimental models that 
attempt to mimic it.  
Data collection in the low-grade CLP model depicts an attempt to wall-off an 
infection. Tissue injury with intra-abdominal abscess formation and necrotic bowels is 
largely documented, and bacteremia is observed only at the late stages. On the other 
hand, the surgery colon ascendens stent peritonitis (CASP) has been shown to reproduce 
the effects of severe, high-grade sepsis [12], and appears to mimic the clinical course of 
diffuse peritonitis, with increasing infection due to persisting intestinal leakage and 
development of a systemic inflammatory response syndrome (SIRS), which plays a 
major role in the rate and the cause of death. The mortality in CASP depends on TLR2 
[13], TLR4 [14], TLR9 [15], MyD88 [16], while antibacterial defenses and survival are 
associated with iNOS[17], IL-12 [17], complement [18] and calcium diastolic leakage 
[19]. The role of TLR4-NLRP3-IL-1β axis in causing cardiac alterations during a high-
grade polymicrobial sepsis remains unknown.  
We have recently demonstrated that the progress of type I diabetes to associated 
heart arrhythmias is mediated by NLRP3 inflammasome activation and IL-1β 
production, promoting CAMKII oxidation and an increase in calcium sparks [20]. We 
have also shown that the heart contractile dysfunction in CASP is mediated by CAMKII 
[19]. Here, we studied the role played by TLR4-NLRP3-IL-1β axis in the electrical and
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mechanical cardiac dysfunction that follows CASP in mice. The results show that 
despite reducing the level of key inflammatory cytokines IL-1β, TNF-α and IL-6, the  
genetic ablation of innate immunity sensors TLR4 and NLRP3 is not capable of 
preventing cardiac dysfunction, indicating that neither these sensors nor the cytokine 
storm evoked by this axis is involved in cardiac depression associated with high-grade 
sepsis. 
MATERIALS AND METHODS 
Animals and experimental protocol 
This study was carried out in strict accordance with the recommendations of the 
Guide for the Care and Use of Laboratory Animals of the Brazilian National Council of 
Animal Experimentation (http://www.cobea.org.br/) and Federal Law 11.794 (October 
8, 2008).  
The protocols of the present study were approved by the Committees for Animal 
Care and Use at the Federal University of Rio de Janeiro (under n°: 137/16). Wild-type 
(WT) C57BL/6J and TLR4 (Tlr4-/-) were kindly provided by Prof. Sergio Costa Oliveira 
at Federal University of Minas Gerais (Belo Horizonte, Brazil), Knockout to NLRP3 
(Nlpr3-/-)(Genentech, USA) (# OM-214220) (21), and CASP-1 (Caspase1-/-) (22)(MTO 
#14865) male mice were generated in the C57BL/6J background. Animals, studied at 
the age of 8–10 weeks, were kept at constant temperature (23 oC) in a standard 
light/dark cycle (12 h/12 h) with free access to standard chow and water. Mice, were 
bred and maintained under specific pathogen-free conditions at the animal facilities of 
the Federal University of Rio de Janeiro, and sacrificed by cervical dislocation. The 
animals were divided in 2 groups: a) Sham mice (Sham) and b) operated mice (CASP). 
CASP surgery procedures were carried out as previously described by Traeger T.et al. 
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(2010), using a specific 14 G catheter [21]. Briefly the procedure to induce CASP is 
characterized by the fixed insertion of a stent (catheter) into the colon ascendens after 
abdominal incision. Fecal content is milked from the cecum into the stent and finally 
may leak from the stent into the peritoneal cavity, which leads to polymicrobial 
peritonitis and subsequently sepsis. The severity of the disease is defined by the 
diameter of the stent, thus here we used a 14 gauge, which induce 100% lethality. 
CLP surgery was carried out as previously described with slight modifications 
[22]. Briefly, mice were anesthetized with isofluorane and a small incision was made in 
the abdomen through which the cecum was externalized. Cecum was ligated at 75% of 
its length and 9 punctures were made using a 16G gauge needle. In pilot experiments, 
we determined that this procedure resulted in similar mortality between CLP and CASP 
models (100% within 48h). Cecum was then returned to the peritoneal cavity and 
wound was closed. Animals received 1 mL subcutaneous saline for fluid reposition and 
analgesics.  
Cardiac mechanical/structural and electrical function 
Left ventricular structural and functional assessment using echocardiography 
In vivo transthoracic echocardiogram was performed using a high resolution 
imaging system (VEVO 770,VisualSonics, Toronto, Ontario, Canada) equipped with a 
30 MHz scanhead (VisualSonics, Toronto, Ontario, Canada). Mice were placed in an 
induction chamber with constant inflow of 2% isoflurane mixed with 100% oxygen. 
Once the mouse was asleep, it was removed from the induction chamber, trichotomized 
in precordial region and placed on a heating platform with electrocardiogram contact
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pads and maintained anesthetized by a nose cone with 1–2% isoflurane in 100% 
oxygen. Excess gases were evacuated passively using an activated charcoal absorption 
filter (VaporGuard, VetEquip, Livermore, California, USA). A rectal probe was 
lubricated with gel, placed in the rectum and taped to the platform. The temperature was 
maintained at 36.5–37.5 °C. B-Mode and M-mode at the level of the papillary muscle 
images were obtained. Quantitative measurements were made offline using analytic 
software (VisualSonics, Toronto, Ontario, Canada). The percent of shortening fraction 
was calculated from M-mode measurements using the leading edge to leading edge 
method via the formula: % Shortening Fraction (%SF) = left ventricular internal 
diameter (diastole) [LVID(d)] − left ventricular internal diameter (systole) 
[LVID(s)]/LVID(d) x 100. Ejection fraction (%EF) as follow: left ventricular diastolic 
volume (LVDV) - left ventricular systolic volume (LVSV) / left ventricular diastolic 
volume (LVDV) x100. Cardiac stroke = left ventricular end diastolic volume (LVEDV) 
– left ventricular end systolic volume (LVESV). Cardiac output: Bpm x stroke volume. 
ECG and cardiac action potential recording 
In order to assess the cardiac electrical activity in vivo, an electrocardiogram 
recording was carried out in conscious animals by noninvasive method. Electrodes were 
positioned in DI derivation and connected by flexible cables to a differential AC 
amplifier (model 1700, A-M Systems, Sequim, Washington USA), with signal low-pass 
filtered at 500 Hz and digitized at 1 kHz by a 16-bit A/D converter (Minidigi 1-D, Axon 
Instruments, Union City, California, USA) using Axoscope 9.0 software (Axon 
Instruments, Union City, California, USA). Data were stored in a PC for offline 
processing. The following parameters were analyzed using LabChart 7.3 software (AD 




Instruments, Bella Vista, New South Wales, Australia). R-R interval and Q-J interval as 
a measurement of early repolarization were also analyzed.  
 To assess cardiac electrical activity an action potential recording was performed. 
Thus, a muscle strips were obtained and placed to the bottom of a tissue bath in order to 
expose the endocardial side. The preparations were superfused with Tyrode's solution 
containing (in mM): 150.8 NaCl, 5.4 KCl, 1.8 CaCl2, 1.0 MgCl2, 11.0 D-glucose, 10.0 
HEPES (pH 7.4 adjusted with NaOH at 37.0 ± 0.5 °C) saturated with carbogen mixture 
(95% O2/5% CO2) at a flowof 5 ml/min (Miniplus3 Gilson, Middleton, Wisconsin, 
USA). The tissue was stimulated at three different basic cycle lengths: 200, 300 and 500 
ms. Transmembrane potential was recorded using glass microelectrodes (10–40 MΩ DC 
resistance) filled with 2.7 M KCl connected to a high input impedance microelectrode 
amplifier (Electro 705, WPI, Sarasota, Florida, USA). Amplified signals were digitized 
(1440 Digidata A/D interface, Axon Instrument Inc., Union City, California, USA) and 
stored in a computer for later analysis using software LabChart 7.3 (ADInstruments, 
Bella Vista, New South Wales, Australia). The following parameters were analyzed: 
resting membrane potential (RMP), action potential amplitude (APA), action potential 
duration at 90% (APD90) and 30% (APD30) repolarization. The Maximum rate of 
depolarization (Vmax) was calculated using five-point linear regression centered on the 
sample. The Maximum Negative Slope (Max. Neg. Slope) was calculated by the 
steepest downhill slope starting 5 ms after the peak using a linear regression during a 
window of 4 ms. The AP triangulation was calculated by subtracting APD40 from 
APD90.




Inflammatory plasma profile 
Blood was harvested from mice and kept for 30 minutes at room temperature. 
Blood was then centrifuged (800g x 15 min) and serum was collected and stored at -80 
until use. A Bioplex Assay Kit (Bio-Rad, Hercules, California, USA) was used to 
measure serum cytokine levels of IL-1β in Sham and Septic WT and Nlrp3-/- mice. To 
measure IL-6, IL-4 and TNF-α a CBA kit (BD, Franklin Lakes, New Jersey, USA) was 
used. 
Statistical analysis 
Data are presented as mean ± SEM. Comparison between two groups was 
analyzed by t-test. Multiple comparisons were performed using analysis of two-way 
variance (ANOVA), followed by Sidak´s post-test to selected pairs. Values of p< 0.05 
were considered statistically significant. All analysis were made using GraphPad Prism 
6.0 (GraphPad Software, La Jolla, California, USA). 
 
RESULTS 
Sepsis by CASP impairs both cardiac electrical and mechanical activity 
In order to assess the cardiac electrical function, ECG was recorded after CASP 
induction in C57BL/6J mice. Prolonged RR and QJ intervals were observed 24 h after 
CASP induction as compared to the sham group (Figure 1A). Mice also presented 
prolonged action potential duration at 90% of repolarization after CASP induction 
(Figure 1B and Supplemental Table 1, http://links.lww.com/SHK/A674). We observed a 
more depressed left ventricular function after CASP surgery than in sham-operated 
controls (Figure 1C), as we previously described [19]. Since sepsis is associated with a 




strong innate immune response and with cardiac dysfunction, we evaluated the 
production of the arrhythmogenic cytokine IL-1β. Much greater amounts of circulating 
IL-1β were found in septic compared to sham-operated mice (Figure 1D). 
TLR4 is not associated with contractile or electrical cardiac dysfunction in CASP 
To investigate the role of TLR4 in the cardiac function during high-grade sepsis, 
we performed CASP in TLR4 deficient mice (Tlr4-/-) and C57BL/6J wild-type mice and 
assessed their cardiac function by electro and echocardiography.The genetic ablation of 
TLR4 (Tlr4-/- mice) did not prevent either electrical (Figure 2A, B) or mechanical 
(Figure 2C) cardiac reactions to CASP, and Tlr4-/- mice presented cardiac alterations 
similar to wild type-septic mice, such as increased RR and QJ intervals, decreased EF 
and FS. The similar behavior of Tlr4-/- and wild-type hearts after CASP show TLR4 is 
not a key molecule regulating the deleterious cardiac alterations. 
The activation of NLRP3 or Caspase 1 is not involved in cardiac deterioration after 
CASP 
Nlrp3-/- mice behaved similarly to wild-type mice concerning electrical (Figure 
3A) and mechanical (Figure 3B) cardiac responses to CASP, undergoing increases in 
RR and QJ intervals and decreases in EF and FS as compared to sham controls, which 
were similar in magnitude to that found in wild-type mice. These data indicate that 
NLRP3 does not participate in the cardiac deterioration that follows induction of high-
grade sepsis. 
The maturation of IL-1β critically depends on caspase-1 activation. This 
phenomenon is a consequence of inflammasome activation [23]. Therefore, since the 
results presented above (Figure 3) strongly suggested that the NLRP3 inflammasome is 
not involved in the CASP-induced cardiac damage, we also tested whether these cardiac 




alterations depend on caspase-1 activation using mice deficient in caspase-1 (Caspase1-
/-). As shown in Figure 4-A, B, neither electrical nor mechanical cardiac function was 
preserved in the Caspase1-/- mice after CASP surgery. Collectively, these data suggest 
that the suppression of this unique pathway does not interfere with the cardiac 
dysfunction induced by CASP. 
NLRP3 controls pro-inflammatory cytokine production in CASP 
In order to understand whether the lack of inflammasome activation could 
interfere with CASP-induced cytokine storm, we measured the level of key circulating 
cytokines. As expected, in Nlrp3-/- mice, the circulating IL-1β did not reach levels as 
high as in wild-type mice after CASP as compared to sham-operated mice (Figure 5A). 
Also, different from wild-type mice, Nlrp3-/- mice reacted to CASP with a blunted 
increase in IL-6 and TNF-α plasma levels (Figure 5B, C). Together, these data indicate 
that NLRP3 activation participates in the production of key inflammatory cytokines 
during CASP-induced high-grade sepsis. The sharp contrast between the similar cardiac 
deterioration found in wild-type and Nlrp3-/- mice and the blunted production of pro-
inflammatory cytokines found in Nlrp3-/- as compared to wild-type mice in response to 
CASP indicates that these pro-inflammatory cytokines are not pivotal in the cardiac 
deterioration induced by CASP. 
Since our results in CASP differed from a previous work which showed 
attenuation of the cardiac deterioration in Nlrp3-/- mice submitted to medium-grade CLP 
[10], we performed high-grade CLP in order to test whether severe polymicrobial sepsis 
could bypass the need for Nlrp3-dependent inflammation to affect cardiac function. 
Systolic (Figure 6A) and electrical (Figure 6B) heart functions were similarly affected 
after WT or Nlrp3-/- mice were submitted to either CLP or CASP surgeries. The 




production of IL-1β, TNF, and IL-6 was blunted in Nlrp3-/- mice submitted to CASP 
when compared to the response of WT mice, but after CLP, similar levels of 
inflammatory cytokines were found in Nlrp3-/- versus WT mice (Figure 6A-C). Thus, 
while the production of pro-inflammatory cytokines depended on the chosen 
polymicrobial sepsis model, our results indicate that when the severity of sepsis is high, 
NLPR3-dependent inflammation is not relevant to the cardiac function. 
DISCUSSION 
Herein, we studied the role played by TLR4-NLRP3-IL-1β axis in the electrical 
and mechanical cardiac dysfunction that follows CASP in mice. We found that the 
genetic deficiency of TLR4, NLRP3, or CASP1 does not interfere with 
cardiacdysfunction in general, despite the profound inhibition of IL-1β, IL-6 and TNF-α 
production in Nlrp3-/- mice after CASP surgery. Our results indicate that IL-1β is 
unlikely to be a feasible therapeutic target in cases of sepsis in which diffuse peritonitis 
and SIRS predominate.  
The genetic deficiency of NLRP3 prevented the decrease in heart rate, stroke 
volume and LV end diastolic volume that occurred after medium-grade CLP surgery 
[10]. On the other hand, we found here similar cardiac responses in WT and Nlrp3-/- 
after high-grade CLP or CASP surgeries, indicating that when the severity of sepsis is 
high, Nlrp3-dependent inflammation is not relevant to the cardiac function. We 
speculate that the reasons for the different results obtained with high-grade CLP and 
CASP performed by us and the previous medium-grade CLP performed by others [10] 
are likely due to the widespread availability of TLR ligands in high-grade sepsis, which 




can dispense with the inflammatory effects of cytokines and act on heart function 
through modulation of autonomic nervous function [24]. 
A previous work on the CLP model of medium-grade sepsis revealed that 
genetic deficiency of NLRP3 was capable of preventing the secretion of the 
inflammasome-dependent cytokine IL-1β and also of the non-NLRP3 related cytokine 
IL-6 [10]. Here we found IL-1β, IL-6 and TNF-α production was drastically decreased 
in Nlrp3-/- mice after high-grade CASP surgery, but not after high-grade CLP. The 
reasons for the discrepancy between medium- and high-grade CLP and also between 
high-grade CLP and CASP concerning NLRP3-dependent pro-inflammatory cytokine 
secretion remain unknown, as well as its relevance to the outcome of polymicrobial 
sepsis. 
Toll-like receptor 4 (TLR4) activates the innate immune system in response to 
microbial products. The result is an inflammatory reaction that has both the benefit of 
clearing a potential infection, but can also result in collateral damage to host tissues. In 
endotoxemia, the TLR4 ligand lipopolysaccharide (LPS) kills the host by inducing a 
severe cytokine storm [25], but in CLP, the genetic ablation of TLR4 worsens cardiac 
function [6], an effect that could stem from the capacity of TLR4 stimulation to increase 
the levels of IL-6 (29). Here we have shown that deficiency of TLR4 does not interfere 
with cardiac dysfunction in the CASP model of sepsis. Also, conditions that drastically 
reduce the levels of IL-6 do not interfere with cardiac dysfunction after CASP, further 
indicating that in high-grade sepsis there is no involvement of IL-6 production in 
cardiac dysfunction. 
We have recently demonstrated that IL-1β is an arrhythmogenic agent per se, 
causing prolongation of the action potential duration, while it also promotes CaMKII 
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oxidation and increases calcium sparks in cardiomyocytes [26]. We have also shown 
that heart contractile dysfunction in CASP is mediated by CAMKII oxidation and 
calcium diastolic leakage [19]. Therefore, we raised the hypothesis that IL-1β could be 
responsible for the prolonged QJ, the CaMKII oxidation, the calcium diastolic leakage 
and the consequent contractile dysfunction after CASP. Nevertheless, genetic deficiency 
of either NLRP3 or caspase-1 did not interfere with cardiac dysfunction after sepsis, 
even though they abrogated the secretion of IL-1β. The redundancy in the effects of pro-
inflammatory cytokines upon cardiomyocytes does not easily fit to explain these results, 
since IL-1β, IL-6 and TNF-α were all greatly reduced in Nlrp3-/- mice. However, we can 
not rule out the cardiac effects of non-studied cytokines which are known to interfere 
with heart physiology and are present in high levels after CASP, such as MIP-1α, IFN-γ, 
and IL-12 [27-29]. Another possibility is that pathogen associated molecular patterns 
other than TLR4 ligands or NLRP3 activators are directly sensed by cardiomyocytes, 
triggering alterations in heart physiology. Still, it is possible that mitochondrial ROS 
produced in response to a secondary metabolic dysfunction in sepsis play a role in 
cardiac dysfunction. 
Our results show that the absence of either TLR4, NLRP3, or caspase-1 does not 
prevent cardiac dysfunction after CASP, but still, the genetic ablation of NLRP3 
abrogates the production of IL-1β, TNF-α and IL-6. Taken together, these results 
indicate that targeting TLR4, NLRP3, caspase-1, or IL-1β is not likely to ameliorate the 
cardiac dysfunction that accompanies the cases of sepsis in which diffuse peritonitis and 
SIRS predominate. These results in the CASP model contrast sharply with the great 
prevention of cardiac dysfunction found in Nlrp3-/- mice submitted to medium-grade 
CLP surgery, but are similar to our cardiac findings in high-grade sepsis, indicating the
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need to distinguish between low, medium and high-grade sepsis in humans in order to propose 
candidate therapies to clinical trials.  
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Figure 1. Impairment of electrical and mechanical cardiac function after CASP.A) 
Representative ECG traces of C57BL/6 WT mice highlighting QJ interval prolongation in CASP 
compared to sham mice (left). RR and QJ intervals duration (right). For all groups, n = 7. B) 
Representative action potential (AP) traces from the endocardial layer of left ventricle strips 
paced at 200 ms basic cycle length (BCL) in sham and CASP WT mice (left). AP duration at 90 
per cent of repolarization (APD90) at different BCL (200, 300 and 500 ms) in both groups 
(right). For all groups, n = 7. C) Echocardiogram parameters of sham and CASP WT mice. SF 
(%): shortening fraction. EF (%): ejection fraction; LVEDV: left ventricular end diastolic 
volume; LVESV: left ventricular end systolic volume. WT sham n = 8 and CASP n = 5. D) IL-
1β serum levels. All parameters were analyzed 24 h post-CASP induction. Results were 
expressed as mean ± SEM. * P < 0.05, ** P < 0.01 and *** P < 0.001. 
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Figure 2. The genetic ablation of TLR4 does not prevent CASP-induced cardiac dysfunction. A) 
Representative ECG traces of Tlr4-/-sham and CASP mice showing QJ interval prolongation after 
CASP (left). RR and QJ intervalS duration of WT and Tlr4-/-sham and CASP groups (right). WT 
sham n = 7, Tlr4-/-sham n = 5, WT CASP n = 7, Tlr4-/-CASP n = 4. B) Echocardiogram 
parameters for WT and Tlr4-/- sham and CASP mice. WT sham n = 8, WT CASP n = 5, Tlr4-/- 
sham n = 5, Tlr4-/-CASP n = 4. Results were expressed as mean ± SEM.  * P < 0.05, ** P < 0.01, 
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Figure 3. The genetic ablation of Nlrp3 does not prevent CASP-induced cardiac dysfunction. A) 
Representative ECG traces of Nlrp3-/-sham and CASP mice highlighting QJ interval prolongation 
in Tlr4-/-after CASP (left). RR and QJ interval duration of WT and Nlrp3-/-sham and CASP 
groups (right). WT sham n = 7, Nlrp3-/- sham n = 4, WT CASP n = 7, Nlrp3-/-CASP n = 6 . B) 
Echocardiogram parameters for WT and Nlrp3-/-sham and CASP mice. WT sham n = 8, Nlrp3-/-
sham n = 5, WT CASP n = 5, Nlrp3-/-CASP n = 7. Results were expressed as mean ± SEM.  * P 
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Figure 4. The genetic ablation of Caspase-1 does not prevent CASP-induced cardiac 
dysfunction. A) Representative ECG traces of caspase-1-/-sham and CASP mice highlighting QJ 
interval prolongation in caspase-1-/- after CASP (left). RR and QJ interval duration of WT and 
caspase1-/- sham and CASP groups (right). WT sham n = 7, WT CASP n = 7, caspase-1-/-sham n 
= 5, caspase-1-/-CASP n = 4. B) Echocardiogram parameters of WT and caspase-1-/-sham and 
CASP mice. WT sham n = 8, CASP n = 5 and caspase-1-/-sham n = 5, caspase-1-/-CASP n = 4. 
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Figure 5. Circulating levels of pro-inflammatory cytokines after CASP depend on Nlrp3. Serum 
levels of cytokines for WT sham, WT CASP, Nlrp3-/-sham and Nlrp3-/- CASP: A) TNF-α, B) IL-
6 and C) IL-1β. Results were expressed as mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001 
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Figure 6. Cardiac function of Nlrp3-/- mice respond similarly to high-grade models of sepsis 
CLP and CASP. A) Left ventricle ejection fraction (EF) and fractional shortening (FS); B) RR 
and QJ interval duration and C) IL-1β, TNF and IL-6 plasma levels of WT and Nlrp3-/- 18 h after 
sham, CASP, or CLP. * P < 0.05, ** P < 0.01, *** P < 0.001,  
# P = 0.06. 
 
 
 
